ArticleMolecular therapy. Advances2026

AI-engineered AAV capsid enables intravitreal delivery for the treatment of diverse retinal degenerations.

Mochen Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.